RAYZACT
Swiss trademark · 839703 · Word mark · In force
Register entry
- Registration number
- 839703
- Application number
- 17223/2025
- Status
- In force
- Type
- Word mark
- Filed
- Nov 13, 2025
- Registered
- Nov 18, 2025
- Published
- Nov 18, 2025
- Protected until
- Nov 13, 2035
- Priority
- 11.06.2025 US
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmaceutical preparations for the treatment and prevention of oncological, haematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, urogenital, hepatological, respiratory, neurological, gastrointestinal, dermatological and psychiatric diseases and disorders, and diseases and disorders related to the immune system; Radiopharmaceuticals for diagnostic purposes
As filed
Pharmazeutische Präparate zur Behandlung und Vorbeugung von onkologischen, hämatologischen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, hepatologischen, respiratorischen, neurologischen, gastrointestinalen, dermatologischen, psychiatrischen und Immunsystem-bezogenen Erkrankungen und Störungen; Radiopharmazeutika für diagnostische Zwecke.
Translated automatically. Only the text as filed is legally binding.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 18, 2025
Registered
Published in Swissreg on 18.11.2025
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.